Literature DB >> 3335704

Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study.

D R Düren1, A E Becker, A J Dunning.   

Abstract

A prospective long-term follow-up study was made of 300 patients with idiopathic mitral valve prolapse, diagnosed by clinical, cineangiographic and echocardiographic criteria. There were 136 male and 164 female patients, ranging in age from 10 to 87 years (mean 42.2). The study included all patients with primary mitral valve prolapse, irrespective of clinical condition at the onset, and excluded only those patients with "secondary" mitral valve prolapse attributable to an accompanying established disorder. The average follow-up period was 6.1 years (range 6 months to 20 years). Two patients died of a noncardiac cause. The clinical condition of 153 patients remained stable. In 27 patients a supraventricular tachycardia occurred that was readily controlled with medication and caused no serious clinical complications. In 20 patients signs of mitral regurgitation appeared, but the patients remained clinically asymptomatic. Serious complications developed in 100 patients. Sudden death, most likely due to ventricular fibrillation, occurred in three patients; documented ventricular fibrillation was seen in two. Ventricular tachycardia developed in 56 patients, but in all instances the rhythm disorder was managed effectively and durably with medication. Infective endocarditis occurred in 18 patients, 4 of whom died during treatment and 6 of whom needed mitral valve replacement. The remaining eight patients suffer from severe mitral regurgitation that will require surgery in the near future. Twenty-eight patients underwent mitral valve operation because of progressive regurgitation. Cerebrovascular accidents occurred in 11 patients, but lifelong treatment with coumarin derivatives or antiplatelet aggregation agents was not considered necessary.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3335704     DOI: 10.1016/0735-1097(88)90164-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  31 in total

Review 1.  Timing of surgery in mitral regurgitation.

Authors:  Catherine M Otto
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 2.  Degenerative mitral valve disease with emphasis on mitral valve prolapse.

Authors:  D Pellerin; S Brecker; C Veyrat
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

3.  Sex differences in morphology and outcomes of mitral valve prolapse.

Authors:  Jean-François Avierinos; Jocelyn Inamo; Francesco Grigioni; Bernard Gersh; Clarence Shub; Maurice Enriquez-Sarano
Journal:  Ann Intern Med       Date:  2008-12-02       Impact factor: 25.391

4.  Mitral valve prolapse: a deeper look.

Authors:  Robert A Levine; Ronen Durst
Journal:  JACC Cardiovasc Imaging       Date:  2008-05

5.  Cardiovascular magnetic resonance, mitral regurgitation and outcomes: the importance of accurate assessment in an era of increasing intervention.

Authors:  Rebecca Kozor; Stuart Grieve; Gemma Figtree; Ravinay Bhindi
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 6.  The long-term outcome of mitral valve repair for mitral valve prolapse.

Authors:  Dania Mohty; Maurice Enriquez-Sarano
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

7.  Mitral valve prolapse--from a normal variant to a pathologic entity.

Authors:  T O Cheng
Journal:  J Gen Intern Med       Date:  1988 Nov-Dec       Impact factor: 5.128

Review 8.  Palpitations: a proper evaluation and approach to effective medical therapy.

Authors:  Christopher C Pickett; Peter J Zimetbaum
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

9.  Nonischemic mitral regurgitation: prognostic value of nonsustained ventricular tachycardia after mitral valve surgery.

Authors:  Oladipupo Olafiranye; Clare A Hochreiter; Jeffrey S Borer; Phyllis G Supino; Edmund M Herrold; Adam S Budzikowski; Ofek Y Hai; Dany Bouraad; Paul D Kligfield; Leonard N Girardi; Karl H Krieger; O Wayne Isom
Journal:  Cardiology       Date:  2013-02-20       Impact factor: 1.869

10.  Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.

Authors:  Katelynn Toomer; Kimberly Sauls; Diana Fulmer; Lilong Guo; Kelsey Moore; Janiece Glover; Rebecca Stairley; Joyce Bischoff; Robert A Levine; Russell A Norris
Journal:  Anat Rec (Hoboken)       Date:  2018-10-05       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.